MELISSA SCHNEGG: Open Payments
NPI 1376008912 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 51 payments from 17 companies in 2025. Trend: 2023 $1,166 · 2024 $1,528 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $284 |
| AstraZeneca Pharmaceuticals LP | 6 | $216 |
| Novo Nordisk Inc | 6 | $98 |
| Exact Sciences Corporation | 4 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $41 |
| Astellas Pharma US Inc | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: QULIPTA, BREZTRI, Cologuard Collection Kit, AIRSUPRA, GEMTESA, Ozempic, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across OH — which companies pay providers there.
